Related Experiment Video
Updated: Jul 21, 2026

Simultaneous PET/MRI Imaging During Mouse Cerebral Hypoxia-ischemia
Published on: September 20, 2015
Multiparametric Analysis Combining DSC-MR Perfusion and [18F]FET-PET is Superior to a Single Parameter Approach for
Jürgen Panholzer1,2, Gertraud Malsiner-Walli3, Bettina Grün3
1Department of Neurology, Kepler University Hospital, Linz, Austria. juergen.panholzer@kepleruniklinikum.at.
Purpose:
Perfusion-weighted (PWI) magnetic resonance imaging (MRI) and O‑(2-[18F]fluoroethyl-)-l-tyrosine ([18F]FET) positron emission tomography (PET) are both useful for discrimination of progressive disease (PD) from radiation necrosis (RN) in patients with gliomas. Previous literature showed that the combined use of FET-PET and MRI-PWI is advantageous; hhowever the increased diagnostic performances were only modest compared to the use of a single modality. Hence, the goal of this study was to further explore the benefit of combining MRI-PWI and [18F]FET-PET for differentiation of PD from RN. Secondarily, we evaluated the usefulness of cerebral blood flow (CBF), mean transit time (MTT) and time to peak (TTP) as previous studies mainly examined cerebral blood volume (CBV).
Methods:
In this single center study, we retrospectively identified patients with WHO grades II-IV gliomas with suspected tumor recurrence, presenting with ambiguous findings on structural MRI. For differentiation of PD from RN we used both MRI-PWI and [18F]FET-PET. Dynamic susceptibility contrast MRI-PWI provided normalized parameters derived from perfusion maps (r(relative)CBV, rCBF, rMTT, rTTP). Static [18F]FET-PET parameters including mean and maximum tumor to brain ratios (TBRmean, TBRmax) were calculated. Based on histopathology and radioclinical follow-up we diagnosed PD in 27 and RN in 10 cases. Using the receiver operating characteristic (ROC) analysis, area under the curve (AUC) values were calculated for single and multiparametric models. The performances of single and multiparametric approaches were assessed with analysis of variance and cross-validation.
Results:
After application of inclusion and exclusion criteria, we included 37 patients in this study. Regarding the in-sample based approach, in single parameter analysis rTBRmean (AUC = 0.91, p < 0.001), rTBRmax (AUC = 0.89, p < 0.001), rTTP (AUC = 0.87, p < 0.001) and rCBVmean (AUC = 0.84, p < 0.001) were efficacious for discrimination of PD from RN. The rCBFmean and rMTT did not reach statistical significance. A classification model consisting of TBRmean, rCBVmean and rTTP achieved an AUC of 0.98 (p < 0.001), outperforming the use of rTBRmean alone, which was the single parametric approach with the highest AUC. Analysis of variance confirmed the superiority of the multiparametric approach over the single parameter one (p = 0.002). While cross-validation attributed the highest AUC value to the model consisting of TBRmean and rCBVmean, it also suggested that the addition of rTTP resulted in the highest accuracy. Overall, multiparametric models performed better than single parameter ones.
Conclusion:
A multiparametric MRI-PWI and [18F]FET-PET model consisting of TBRmean, rCBVmean and PWI rTTP significantly outperformed the use of rTBRmean alone, which was the best single parameter approach. Secondarily, we firstly report the potential usefulness of PWI rTTP for discrimination of PD from RN in patients with glioma; however, for validation of our findings the prospective studies with larger patient samples are necessary.
Insights
Combining perfusion-weighted MRI and [18F]FET-PET imaging improves the differentiation of progressive disease from radiation necrosis in glioma patients. A multiparametric model significantly outperformed single-modality approaches, offering enhanced diagnostic accuracy.
Area of Science:
- Neuro-oncology
- Radiology
- Nuclear Medicine
Background:
- Distinguishing progressive disease (PD) from radiation necrosis (RN) in gliomas is crucial for treatment planning.
- Perfusion-weighted MRI (PWI) and O‑(2-[18F]fluoroethyl-)-l-tyrosine ([18F]FET) PET are established imaging modalities for this differentiation.
- Previous studies indicated modest improvements when combining these modalities compared to single-modality use.
Purpose of the Study:
- To investigate the enhanced diagnostic performance of combining MRI-PWI and [18F]FET-PET for differentiating PD from RN in glioma patients.
- To evaluate the specific contributions of cerebral blood flow (CBF), mean transit time (MTT), and time to peak (TTP) parameters from PWI.
Main Methods:
- Retrospective analysis of 37 patients with WHO grades II-IV gliomas and ambiguous findings on structural MRI.
- Utilized dynamic susceptibility contrast MRI-PWI (rCBV, rCBF, rMTT, rTTP) and static [18F]FET-PET (TBRmean, TBRmax).
- Compared single and multiparametric models using ROC analysis, ANOVA, and cross-validation, with histopathology/follow-up as the gold standard.
Main Results:
- Single parameters like TBRmean (AUC=0.91), TBRmax (AUC=0.89), and rTTP (AUC=0.87) showed efficacy in differentiating PD from RN.
- A multiparametric model combining TBRmean, rCBVmean, and rTTP achieved a significantly higher AUC of 0.98 (p<0.001).
- The multiparametric approach demonstrated superior performance compared to single-parameter models (p=0.002).
Conclusions:
- A multiparametric model integrating MRI-PWI (rTTP) and [18F]FET-PET (TBRmean, rCBVmean) significantly improves the differentiation of PD from RN in gliomas.
- This study highlights the potential utility of PWI rTTP in this diagnostic context.
- Prospective studies with larger cohorts are recommended for validation.
Related Concept Videos
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET

![Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58641.jpg&w=3840&q=50)